Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiopronin Dose Escalation in Cystinuria
NCT03663855Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tiopronin in cystinuria (CSNU), sponsored by NYU Langone Health. Started Nov 2018; status: completed.
02
Drugs
tiopronin
03
Conditions
cystinuria (CSNU)
Beyond the preview
Go deeper on NCT03663855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663855.